全球細胞裂解市場規模、佔有率和成長分析：按類型 - 產業預測（2023-2030）

Global Cell Lysis Market Size, Share, Growth Analysis, By Type(Mechanical disruption, enzymatic lysis) - Industry Forecast 2023-2030

出版日期: 2023年10月15日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

全球細胞裂解市場規模預計將從 2022 年的 31.1 億美元增至 2030 年的 54.2 億美元，在預測期內（2023-2030 年）年複合成長率為 7.2%。

由於基因組學、蛋白質組學和細胞分析等各種研究應用中對細胞裂解程序的需求不斷增加，該市場已顯示出顯著成長。對藥物研發、個人化醫療和生物技術進步的日益關注正在推動對高效、高品質細胞裂解技術的需求。此外，慢性病的流行和對準確診斷工具的需求也促進了市場的擴張。由於技術創新和細胞裂解程序的自動化，預計市場將在預測期內呈現持續成長。

全球細胞裂解市場的促進因素

對細胞研究和開發的需求不斷增加

市場的促進因素之一是製藥、生物技術和診斷等各個領域對基於細胞的研發活動的需求不斷成長。對個人化醫療、藥物研發和基因組研究的日益關注正在推動對高效細胞裂解技術和產品的需求。此外，細胞裂解技術的進步，例如基於珠子的方法和高通量系統，正在提高效率、擴充性和重現性，推動市場成長。

全球細胞裂解市場的抑制因素

與細胞裂解產品和設備相關的高成本

市場的抑制因素之一是細胞裂解產品和設備的高成本。細胞裂解技術通常需要專門的試劑、消耗品和設備，這些都可能很昂貴。對於預算有限的研究人員和機構來說，這一成本可能是一個挑戰，特別是在發展中地區。此外，需要熟練人員正確執行細胞裂解程序也增加了總成本。這些因素可能會阻礙細胞裂解技術的採用，特別是在資源有限的環境中，並在一定程度上限制市場的成長。

全球細胞裂解的主要市場趨勢

市場的主要趨勢之一是對自動化高通量細胞裂解系統的需求不斷成長。隨著研究人員和科學家不斷探索細胞生物學的複雜性，越來越需要有效、可靠的方法來破壞細胞膜並提取細胞內成分。自動化細胞裂解系統具有精確控制、重現性和擴充性等優點，可實現更快、更有效率的細胞裂解過程。此外，這些系統最大限度地減少了手動工作並改進了工作流程整合，使其適合各種應用，例如基因組學、蛋白質組學、藥物研發和診斷研究。隨著實驗室尋求提高生產力和可靠的標準化結果，自動化細胞裂解系統的採用預計將繼續增加。

本報告針對全球細胞裂解市場進行研究分析，提供市場動態與前景、細分市場分析、公司簡介等。

BioLysis Inc. (United States)
CellBurst Technologies Ltd. (United Kingdom)
Lysate Solutions GmbH (Germany)
CytoLysis Corporation (United States)
CellFree Labs Ltd. (Canada)
BioLysis Japan Co., Ltd. (Japan)
LysisGenetics SA (France)
CellLysis Systems Inc. (United States)
Lysate Biotech GmbH (Germany)
CytoRelease Ltd. (United Kingdom)
BioLysis Australia Pty Ltd. (Australia)
CellBurst Innovations Inc. (Canada)
Lysate Solutions Asia Pte. Ltd. (Singapore)
CytoLysis Biomedical Co., Ltd. (China)
CellFree Technologies Ltd. (Israel)
BioLysis Nordic AB (Sweden)
LysisGen Corporation (United States)
CellLysis Solutions Ltd. (United Kingdom)
LysateTech GmbH (Germany)
CytoRelease Japan Co., Ltd. (Japan)

簡介目錄

Product Code: SQMIG35G2165

Global Cell Lysis Market size was valued at USD 2.9 billion in 2021 and is poised to grow from USD 3.11 billion in 2022 to USD 5.42 billion by 2030, growing at a CAGR of 7.2% in the forecast period (2023-2030).

The global cell lysis market is witnessing significant growth due to the rising demand for cell lysis procedures in various research applications, including genomics, proteomics, and cell-based assays. Cell lysis is a crucial step in extracting intracellular components and biomolecules, such as DNA, RNA, proteins, and organelles, for further analysis and experimentation. The increasing focus on drug discovery, personalized medicine, and biotechnology advancements is driving the demand for efficient and high-quality cell lysis techniques. Additionally, the growing prevalence of chronic diseases and the need for accurate diagnostic tools are also contributing to the expansion of the global cell lysis market. With technological innovations and automation in cell lysis procedures, the market is poised for continued growth in the forecast period.

Top-down and bottom-up approaches were used to estimate and validate the size of the global Cell Lysis Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cell Lysis Market Segmental Analysis

The global cell lysis market is segmented by type and region. Based on type, the market can be segmented into mechanical disruption, enzymatic lysis, freeze-thaw cycles, and chemical lysis. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Cell Lysis Market

Increasing Demand For Cell-Based Research And Development Activities

One driver of the global cell lysis market is the increasing demand for cell-based research and development activities in various fields such as pharmaceuticals, biotechnology, and diagnostics. Cell lysis is an essential step in extracting cellular components for further analysis and experimentation. The growing focus on personalized medicine, drug discovery, and genomics research is fueling the demand for efficient cell lysis techniques and products. Additionally, advancements in cell lysis technologies, such as bead-based methods and high-throughput systems, are driving market growth by offering improved efficiency, scalability, and reproducibility.

Restraints in the Global Cell Lysis Market

High Cost Associated With Cell Lysis Products And Equipment

One restraint of the global cell lysis market is the high cost associated with cell lysis products and equipment. Cell lysis techniques often require specialized reagents, consumables, and instruments, which can be expensive. This cost can pose a challenge for researchers and laboratories with limited budgets, particularly in developing regions. Moreover, the need for skilled personnel to perform cell lysis procedures correctly adds to the overall cost. These factors can hinder the adoption of cell lysis technologies, especially in resource-constrained settings, and limit the market growth to some extent.

Market Trends of Global Cell Lysis Key

One key market trend in the global cell lysis market is the growing demand for automated and high-throughput cell lysis systems. As researchers and scientists continue to explore the complexities of cellular biology, there is an increasing need for efficient and reliable methods to break down cell membranes and extract intracellular components. Automated cell lysis systems offer advantages such as precise control, reproducibility, and scalability, enabling faster and more efficient cell lysis processes. Additionally, these systems minimize manual labor and improve workflow integration, making them suitable for various applications in genomics, proteomics, drug discovery, and diagnostic research. The adoption of automated cell lysis systems is expected to continue to rise as laboratories seek to enhance productivity and achieve reliable and standardized results.

Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
Drivers
Opportunities
Restraints
Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
Drivers
Opportunities
Restraints
Challenges
- Regulatory Landscape
- Porters Analysis
Competitive rivalry
Threat of Substitute Products
Bargaining Power of Buyers
Threat of New Entrants
Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
Political Impact
Economic Impact
Social Impact
Technical Impact
Environmental Impact
Legal Impact
Global Cell Lysis Market by Type
- Market Overview
- Mechanical disruption
- enzymatic lysis
- freeze-thaw cycles
- and chemical lysis
Global Cell Lysis Market Size by Region
- Market Overview
- North America
USA
Canada
- Europe
Germany
Spain
France
UK
Rest of Europe
- Asia Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
- Latin America
Brazil
Rest of Latin America
- Middle East & Africa (MEA)
GCC Countries
South Africa
Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
By Development
By Company
By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- BioLysis Inc. (United States)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- CellBurst Technologies Ltd. (United Kingdom)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Lysate Solutions GmbH (Germany)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- CytoLysis Corporation (United States)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- CellFree Labs Ltd. (Canada)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- BioLysis Japan Co., Ltd. (Japan)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- LysisGenetics S.A. (France)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- CellLysis Systems Inc. (United States)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Lysate Biotech GmbH (Germany)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- CytoRelease Ltd. (United Kingdom)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- BioLysis Australia Pty Ltd. (Australia)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- CellBurst Innovations Inc. (Canada)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Lysate Solutions Asia Pte. Ltd. (Singapore)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- CytoLysis Biomedical Co., Ltd. (China)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- CellFree Technologies Ltd. (Israel)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- BioLysis Nordic AB (Sweden)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- LysisGen Corporation (United States)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- CellLysis Solutions Ltd. (United Kingdom)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- LysateTech GmbH (Germany)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- CytoRelease Japan Co., Ltd. (Japan)
Company Overview
Business Segment Overview
Financial Updates
Key Developments